About T1D research
JDRF funds research that can benefit everyone with type 1 diabetes (T1D). We continually strive to improve the lives of people with T1D, until we reach our end goal: a world without T1D. Our mission is to accelerate life-changing breakthoughs to cure, prevent and treat T1D and its complications.
Together, we’ve achieved all this in the past 12 months
What will be possible next year because of JDRF One Walk?
June 2017 – Longest and largest at-home trials of a hybrid closed-loop insulin pump system underway around the country.
May 2017 – A new glucose-responsive insulin (GRI) technique that uses a modified insulin and red blood cell delivery system effectively reduced blood sugar levels for more than 48 hours in mice.
March 2017 – ‘Medicinal food’ diet counters onset of type 1 diabetes (Monash University).
March 2017 – TEDDY Study: benefits to diagnosis before type 1 diabetes symptoms appear, including reduced risk of potentially fatal diabetic ketoacidosis at diagnosis.
February 2017 – Exercise and type 1 diabetes: world-first guidelines consensus – T1D experts, including three Aussie-based researchers.
January 2017 – Confirmed link between enteroviruses and the development of T1D.
November 2016 – Study finds that people with T1D are at an increased risk of developing other autoimmune diseases.
October 2016 –Improved management: New algorithms for insulin dose calculations to cover meals based on mix of food types.
September 2016 – First audit of national data from Australia’s unique registry highlights an urgent need to improve glycaemic control in young people with T1D (Australasian Diabetes Data Network (ADDN).
August 2016 – Common genetic and environmental risk factors between T1D and multiple sclerosis (MS) revealed.
August 2016 – Pioneering research using artificial skin to treat type 1 diabetes (Royal Adelaide Hospital)